CAMP4 Therapeutics Corporation

NasdaqGM CAMP

CAMP4 Therapeutics Corporation Market Capitalization on January 14, 2025: USD 75.40 M

CAMP4 Therapeutics Corporation Market Capitalization is USD 75.40 M on January 14, 2025, a -14.02% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

CAMP4 Therapeutics Corporation 52-week high Market Capitalization is USD 236.69 M on November 12, 2024, which is 213.90% above the current Market Capitalization.
CAMP4 Therapeutics Corporation 52-week low Market Capitalization is USD 3.08 M on June 12, 2024, which is -95.92% below the current Market Capitalization.
CAMP4 Therapeutics Corporation average Market Capitalization for the last 52 weeks is USD 91.39 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqGM: CAMP

CAMP4 Therapeutics Corporation

CEO	Mr. Joshua Mandel-Brehm
IPO Date	Oct. 11, 2024
Location	United States
Headquarters	One Kendall Square Bldg 1400 West, 3rd Floor
Employees	58
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Key trends

Past 5 years